Government invests in global partnership to treat gonorrhoea

£ 3.5 million investment will enable global access to treatment, including in low-middle-income countries, and fund Global Antibiotic Research and Development Partnership ' s development of oral antibiotic zoliflodacin for treatment of gonorrhoea, now in late stage clinical trials.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news